NCT02073903

Brief Summary

The purpose of this study is to introduce new technology and interpreter practices in the inpatient setting at MSKCC. We plan to install dual handset phones at the bedsides of limited English proficiency (LEP) patients and to assess the impact on both patient and physician communication effectiveness with this technology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2014

Completed
Same day until next milestone

Study Start

First participant enrolled

February 24, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 27, 2014

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2020

Completed
Last Updated

January 14, 2020

Status Verified

January 1, 2020

Enrollment Period

5.9 years

First QC Date

February 24, 2014

Last Update Submit

January 13, 2020

Conditions

Keywords

dual handset interpreter phonescommunication14-042

Outcome Measures

Primary Outcomes (1)

  • Patient communication effectiveness

    with the dual handset phones assessed by the survey

    1 year

Secondary Outcomes (1)

  • Physician and nurse communication effectiveness

    1 year

Study Arms (1)

LEP inpatients and their providers

This is a feasibility project with the goal of improving communication between limited English proficiency (LEP )inpatients and their providers. Quantitative data will be obtained via two surveys: a patient survey to assess patients' feedback on the effectiveness of the communication during their hospital stay and their understanding of their medical care, and a provider survey to assess the handset's impact on the effectiveness of the communication. From this data we will be able to assess patient and provider communication effectiveness with both the current various practices at MSKCC and the new intervention.

Behavioral: Patient SurveyBehavioral: Provider Survey

Interventions

Patient SurveyBEHAVIORAL
LEP inpatients and their providers
Provider SurveyBEHAVIORAL
LEP inpatients and their providers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient Support Services will generate a daily list of inpatients that prefer to communicate in a language other than English.

You may qualify if:

  • LEP patients identified by the Department of Interpreter Services at MSKCC admitted to the Hepatobiliary surgery service, the Colorectal Surgery service the GMT surgery service, GI, GU, Breast, General Medicine, Leukemia, or Lymphoma services with a primary language of Spanish, Russian, or Chinese.
  • LEP patients who are expected to have at least a two days hospital course.
  • Patients who are alert and oriented to person, place, and time as determined by the medical doctor taking care of the patient
  • Patients who are willing to participate and complete the survey
  • Patients whose physicians and nurses are willing to participate
  • Only persons ≥ 18 will be included and there will be no children.
  • Providers must be willing to participate and complete the survey
  • TY interns cannot complete provider surveys

You may not qualify if:

  • Patients on contact isolation
  • Patients who previously completed the survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

MeSH Terms

Conditions

Communication

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Chhavi Kumar, MD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2014

First Posted

February 27, 2014

Study Start

February 24, 2014

Primary Completion

January 8, 2020

Study Completion

January 8, 2020

Last Updated

January 14, 2020

Record last verified: 2020-01

Locations